Dexcom (DXCM) Return on Invested Capital (2012 - 2017)

Dexcom (DXCM) has 4 years of Return on Invested Capital data on file, last reported at 0.01% in Q4 2017.

• On a quarterly basis, Return on Invested Capital rose 22.0% year-over-year to 0.01% in Q4 2017; TTM through Dec 2017 was 0.01%, a 22.0% increase from a year earlier, with the FY2015 full-year figure at 0.25%, down 15.0% from the prior year.
• Return on Invested Capital for Q4 2017 stood at 0.01%, up from 0.01% in the prior quarter.
• Over the last five years, Return on Invested Capital for DXCM reached as high as 0.01% in Q4 2017 and fell as low as 0.23% in Q4 2016.
• Historically, Return on Invested Capital has averaged 0.07% across 3 years, with a median of 0.06% in 2015.
• Across the five-year window, Return on Invested Capital slipped 17 bps in 2016 and rose 22 bps in 2017, its largest moves.
• Year by year, Return on Invested Capital stood at 0.06% in 2015, then sank by 280 bps to 0.23% in 2016, then jumped by 97 bps to 0.01% in 2017.
• Per Business Quant data, the three most recent Return on Invested Capital figures were 0.01% in Q4 2017, 0.01% in Q3 2017, and 0.01% in Q2 2017.